Rating
Buy
Price target
$255
Previous
$215
Implied upside
+23%

BofA Securities analyst Mariana Perez Mora raised the price target on Palantir to $255 (from $215) while maintaining a Buy rating.

“On the notion of real vs. fake “AI” – we continue to expect growth would accelerate as more businesses and government realize the choices in front of them.

PLTR’s “red pill” offers boot camps, an expensive software kit, deep FDE expertise, an Ontology implementation path that prioritizes ROI, and the ability to scale with AI FDEs.

We still view this go-to-market and approach as a winning differentiated formula while others continue to push a “blue pill” option: generic, one-size-fits-most, Chat-GPT wrappers.

We reiterate our Buy rating and raise our PO to $255 (from $215) which reflects our confidence in PTLR’s enduring position and better than expected growth (see details on page 4) on a 15x EV/EBITDA on 2035E (unchanged).”

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Privacy Preference Center

Share on